ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease

Summary

The purpose of this study is to evaluate the long-term safety and tolerability of ELND005 beyond the 18 months of treatment in original randomized and blinded clinical trail ELND005-AD201.

Timeline

Start

2009-06

Primary completion

2011-06

Completion

2011-06

Drugs

Indications